
5001 - 10000 employees
🧬 Biotechnology
🏥 Healthcare
💰 $750M Post-IPO Debt - Qiagen on 2025-08
Biotechnology • Healthcare
QIAGEN is a global provider of sample and assay technologies and related systems for molecular diagnostics, applied testing, academic and pharmaceutical research. The company supplies instruments, consumable kits and assays (including PCR and nucleic-acid–based workflows), as well as software and bioinformatics solutions that support clinical laboratories, life-science research, and drug development. QIAGEN’s offerings focus on enabling detection, extraction, and analysis of biological samples for diagnostics, research and applied molecular testing.
Selected: 🇬🇧 United Kingdom – Remote (UK).
Selected: 🆕 Date Added.
🕒 2 days ago
Strategic Account Manager expanding QIAGEN’s QuantiFERON tuberculosis diagnostics across Northern UK and Ireland. Building clinical relationships, strategic accounts and new business through field-based healthcare sales.
🌐 United Kingdom, Ireland – Remote
💰 $750M Post-IPO Debt - Qiagen on 2025-08
⏰ Full Time
🟡 Mid-level
🟠 Senior
💰 Account Manager
👻 Ghost score 10%